Artificial Organs and Bionics Market Trends, Industry | 2030

Artificial Organs and Bionics Market Trends, Industry | 2030

Segments - Artificial Organs and Bionics Market by Types (Artificial Organs [Cochlear Implants, Artificial Heart, Artificial Lungs, Artificial Kidney, and Others] and Bionics [Ear Bionics, Vision Bionics, Cardiac Bionics, and Orthopedic Bionics]), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-3087 | 4.1 Rating | 80 Reviews | 194 Pages | Format : PDF Excel PPT

Report Description


The global artificial organs and bionics market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising demand for advanced medical treatments and increasing number of surgical procedures.

Artificial Organs and Bionics Market summary

An artificial organ is a human made organ device that is implanted into the human body. The newly integrated tissues interface with the living tissues to replace the natural organ with a duplicate organ. The implantation results into the augmentation of a specific function or group of functions to initiate normal life processes. The most common example is the replacement bones and joints, such as those found in hip replacements. The constructing and installing artificial organs is an extremely research-intensive and expensive process. The process initially entails many years of ongoing maintenance services and high medical expenditures. The medical implantation surgeries aid in providing life support to prevent imminent death, improving the patient ability for self care, and enhancing the quality of life through cosmetic restoration after a surgery or an accident. On the other hand, bionics is the application of biological methods and systems to the study and design of engineering systems and modern technology. Bionics is also called as biologically inspired engineering. The study of bionics has produced artificial neurons, artificial neural networks, and swarm intelligence. However, in medicine, bionics means the replacement or enhancement of the body organs. Bionic implants are different from mere prostheses. The bionics comprises of mimicking the original function very closely and sometimes even surpassing it.

The COVID-19 pandemic had significantly affected the dynamics of various industries including healthcare industry. The high risk of developing serious illness due to coronavirus disease has made it challenging for several other healthcare problems. The outbreak situation resulted into nationwide lockdowns, which disrupted the supply of healthcare facilities and manufacturing of surgical devices. The stringent regulations and slowdown in economy hampered the growth of the organs and bionics market.

  • Rising aging population and increasing prevalence of heart & kidney disorders are the major factors anticipated to fuel the growth of the market in the coming years.
  • Increasing disposable income of the urban population and large-scale adoption of advanced technology are expected to spur the market growth during the forecast period.
  • Growing health awareness and unhealthy lifestyle are some of the factor propelling the market expansion during the projected timeline.
  • High cost associated with body parts implantation and lacks of awareness regarding the artificial organ in under developed economies are anticipated to hamper the market growth in the coming years.
  • Increasing research & developments activities for innovative products launches and growing industrial investments for the expansion of product line and offerings is expected to offer immense opportunities for the market players in the long run.

Scope of the Report

The report on the global artificial organs and bionics network market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Artificial Organs and Bionics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Artificial Organs [Cochlear Implants, Artificial Heart, Artificial Lungs, Artificial Kidney, and Others] and Bionics [Ear Bionics, Vision Bionics, Cardiac Bionics, and Orthopedic Bionics])

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Boston Scientific Corporation; Abiomed Inc; Medtronic Inc.; Ossur; and Baxter

Artificial Organs and Bionics Market Segment Insights

Artificial kidney sub-segment is anticipated to register a substantial CAGR

On the basis of types, the market is bifurcated into artificial organs and bionics. The artificial organs segment is further segregated into cochlear implants, artificial heart, artificial lungs, artificial kidney, and others. The bionics segment is categorized as ear bionics, vision bionics, cardiac bionics, and orthopedic bionics. The artificial kidney sub-segment is anticipated to register a substantial CAGR during the projected period owing to the increasing geriatric population and growing kidney disorders. Moreover, increasing technological developments in artificial kidney devices and related fields are anticipated the growth of the market segment in the coming years. Furthermore, the rising awareness about various kidney-related disorders and associated treatment are expected to boost the growth of the market segment during the projected timeline. However, the bionics segment is expected to register at a rapid pace during the forecast period owing to the growing adoption of novel medical bionics as a therapy in emerging markets.

Artificial Organs and Bionics Market type

North America market is anticipated to dominate the market

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is anticipated to expand at a significant CAGR during the forecast period owing to the emergence of new healthcare facilities. Furthermore, the growing income level, unhealthy lifestyle, and increasing medical expenditure are anticipated to fuel the market segment in the coming years. On the other hand, the market in Asia Pacific is expected to grow at a significant rate during the forecast period due to the rising innovation, globalization, and commoditization of products.

Artificial Organs and Bionics Market region

Segments

The global artificial organs and bionics market has been segmented on the basis of

Types

  • Artificial Organs
    • Cochlear Implants
    • Artificial Heart
    • Artificial Lungs
    • Artificial Kidney
    • Others
  • Bionics
    • Ear Bionics
    • Vision Bionics
    • Cardiac Bionics
    • Orthopedic Bionics

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Boston Scientific Corporation
  • Abiomed Inc
  • Medtronic Inc.
  • Ossur
  • Baxter

Competitive Landscape

Key players competing in the global artificial organs and bionics market are Boston Scientific Corporation; Abiomed Inc; Medtronic Inc.; Ossur; and Baxter. The companies are focusing on business strategies, collaborations, research & development activities, and forming strong distribution network to improve their competitive position in the market.

Artificial Organs and Bionics Market keyplayers

In November 2021, Medtronic Inc. planned to set up a global research & development center involving an investment of around USD 159 million at Hyderabad, India. The initiative facilitated the research work for medical products to treat over 70 health conditions that include cardiac devices, cranial & spine robotics, surgical tools, insulin pumps, patient monitoring systems, and others.

In January 2021, Boston Scientific Corporation announced the reallocation of its cardiac rhythm management and research & development resources. The reallocation aimed to increase productivity, innovation, and competitiveness to enhance the ability to deliver new products to the physicians and patients.
In October 2019, Abiomed Inc announced the 1,000th patient has been treated with the Impella heart pump in Japan. The Impella 2.5 and Impella 5.0 heart pumps are approved for the treatment of drug-resistant acute heart failure. The Impella heart pump are the first and only percutaneous temporary ventricular support devices that are Pharmaceuticals and Medical Devices Agency (PMDA) approved. The Impella, a minimally invasive therapy is capable of taking over the pumping function of the heart and blood circulation in the body while the heart rests and recovers.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs and Bionics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Artificial Organs and Bionics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Artificial Organs and Bionics Market - Supply Chain
  4.5. Global Artificial Organs and Bionics Market Forecast
     4.5.1. Artificial Organs and Bionics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Artificial Organs and Bionics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Artificial Organs and Bionics Market Absolute $ Opportunity
5. Global Artificial Organs and Bionics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Artificial Organs and Bionics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Artificial Organs and Bionics Demand Share Forecast, 2019-2026
6. North America Artificial Organs and Bionics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Artificial Organs and Bionics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Artificial Organs and Bionics Demand Share Forecast, 2019-2026
7. Latin America Artificial Organs and Bionics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Artificial Organs and Bionics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Artificial Organs and Bionics Demand Share Forecast, 2019-2026
8. Europe Artificial Organs and Bionics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Artificial Organs and Bionics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Artificial Organs and Bionics Demand Share Forecast, 2019-2026
9. Asia Pacific Artificial Organs and Bionics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Artificial Organs and Bionics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Artificial Organs and Bionics Demand Share Forecast, 2019-2026
10. Middle East & Africa Artificial Organs and Bionics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Artificial Organs and Bionics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Artificial Organs and Bionics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Artificial Organs and Bionics Market: Market Share Analysis
  11.2. Artificial Organs and Bionics Distributors and Customers
  11.3. Artificial Organs and Bionics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Boston Scientific Corporation
     11.4.2. Abiomed Inc
     11.4.3. Medtronic Inc.
     11.4.4. Ossur
     11.4.5. Baxter

Methodology

Our Clients

General Mills
Deloitte
Siemens Healthcare
Dassault Aviation
The John Holland Group
Honda Motor Co. Ltd.
sinopec
Microsoft